194 related articles for article (PubMed ID: 31881446)
1. Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.
Fakhry C; Waterboer T; Westra WH; Rooper LM; Windon M; Troy T; Koch W; Gourin CG; Bender N; Yavvari S; Kiess AP; Miles BA; Ryan WR; Ha PK; Eisele DW; D'Souza G
Oral Oncol; 2020 Feb; 101():104522. PubMed ID: 31881446
[TBL] [Abstract][Full Text] [Related]
2. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.
Brenner N; Mentzer AJ; Hill M; Almond R; Allen N; Pawlita M; Waterboer T
EBioMedicine; 2020 Dec; 62():103123. PubMed ID: 33248371
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Herrero R; Castellsagué X; Pawlita M; Lissowska J; Kee F; Balaram P; Rajkumar T; Sridhar H; Rose B; Pintos J; Fernández L; Idris A; Sánchez MJ; Nieto A; Talamini R; Tavani A; Bosch FX; Reidel U; Snijders PJ; Meijer CJ; Viscidi R; Muñoz N; Franceschi S;
J Natl Cancer Inst; 2003 Dec; 95(23):1772-83. PubMed ID: 14652239
[TBL] [Abstract][Full Text] [Related]
7. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
[TBL] [Abstract][Full Text] [Related]
8. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
Smith EM; Ritchie JM; Summersgill KF; Klussmann JP; Lee JH; Wang D; Haugen TH; Turek LP
Int J Cancer; 2004 Feb; 108(5):766-72. PubMed ID: 14696105
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.
Kreimer AR; Johansson M; Yanik EL; Katki HA; Check DP; Lang Kuhs KA; Willhauck-Fleckenstein M; Holzinger D; Hildesheim A; Pfeiffer R; Williams C; Freedman ND; Huang WY; Purdue MP; Michel A; Pawlita M; Brennan P; Waterboer T
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376197
[TBL] [Abstract][Full Text] [Related]
10. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
12. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Zhang Y; Fakhry C; D'Souza G
JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma.
Windon MJ; D'Souza G; Waterboer T; Rooper L; Westra WH; Troy T; Pardoll D; Tan M; Yavvari S; Kiess AP; Miles B; Mydlarz WK; Ha PK; Bender N; Eisele DW; Fakhry C
Head Neck; 2020 Aug; 42(8):1954-1962. PubMed ID: 32101350
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
[TBL] [Abstract][Full Text] [Related]
15. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
[TBL] [Abstract][Full Text] [Related]
16. Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.
Mena M; Taberna M; Monfil L; Arbyn M; de Sanjosé S; Bosch FX; Alemany L; Bruni L
J Infect Dis; 2019 Apr; 219(10):1574-1585. PubMed ID: 30590684
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
[TBL] [Abstract][Full Text] [Related]
18. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
[TBL] [Abstract][Full Text] [Related]
20. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection.
D'Souza G; Cullen K; Bowie J; Thorpe R; Fakhry C
PLoS One; 2014; 9(1):e86023. PubMed ID: 24475067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
